BCL-2 overexpression is found to be associated with different types of cancers such as prostate cancer, chronic lymphocytic leukemia, non-small cell lung cancer, breast cancer, esophageal cancer, lung cancer, and endometrial cancer [21–25]. This evidence concerns the gene BCL2 and Familial prostate cancer.